Firm is distributing letters to physicians suggesting ways to mitigate the observed contracture of the eye tissues after implantation. Letters will be sent 2/9/2004.
Initiated
2004-02-09
Root cause
Other
Terminated
2005-01-04
Distribution
Nationwide and to Australia, Canada, Chile, France, Germany, India, Lebanon, South Africa, Switzerland, United Kingdom.
Recall number
Z-0539-04
Recall status
Terminated
CDRH record ID
31464
FDA classified
2004-02-18
Recall event number
28264
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.